1 June 2020 in The American Journal of Pathology
2 October 2024 in Science Translational Medicine
MYC promotes tumor growth through multiple mechanisms. Here, we show that, in human glioblastomas, the variant MYC transcript encodes a 114–amino acid peptide, MYC pre-mRNA encoded protein (MPEP), from the upstream open reading frame (uORF) MPEP . Secreted MPEP promotes patient-derived xenograft tumor growth in vivo, independent of MYC through direct binding, and activation of tropomyosin receptor kinase B (TRKB), which induces downstream AKT-mTOR signaling. Targeting MPEP through genetic ablation reduced growth of patient-derived 4121 and 3691 glioblastoma stem cells. Administration of an MPEP-neutralizing antibody in combination with a small-molecule TRKB inhibitor reduced glioblastoma growth in patient-derived xenograft tumor–bearing mice. The overexpression of MPEP in surgical glioblastoma specimens predicted a poor prognosis, supporting its clinical relevance. In summary, our results demonstrate that tumor-specific translation of a MYC -associated uORF promotes glioblastoma growth, suggesting a new therapeutic strategy for glioblastoma.
24 March 2025 in World Neurosurgery
To investigate the identification and management techniques and strategies for cortical dangerous veins during neurosurgical craniotomies. We retrospectively analyzed 37 patients who underwent craniotomies involving the intraoperative protection of cortical dangerous veins between July 2022 and June 2024. Preoperatively, high-resolution MRI data were used for three-dimensional visualization to delineate the resection margins and plan the management of related cortical dangerous veins, including bridging veins, superficial Sylvian veins, anastomotic veins, and veins in the eloquent cortex. Intraoperatively, attention was paid to preserving the cortical dangerous veins. Postoperatively, venous flow disturbances were assessed on the basis of symptoms, imaging findings, physical examinations, and other clinical findings. Preoperative three-dimensional visualization of the cerebral structures and veins corresponded to the intraoperative observations in all 37 patients. Forty-seven cortical dangerous veins were dissected and protected intraoperatively, including 14 bridging veins, five superficial Sylvian veins, eight anastomotic veins, and 20 veins involving the central lobe. Six patients experienced intraoperative venous injury, which was managed by suturing or pressure hemostasis. No patient exhibited definite postoperative symptoms or radiological changes attributable to venous infarction. This study highlights the importance of integrating cortical dangerous vein protection into surgical planning and lesion resection. Employing three-dimensional visualization to advance identification of cortical dangerous veins and preserve vein integrity during resection may mitigate postoperative venous infarction-related deficits without adversely affecting treatment efficacy.